ASCO 2014: People in Drug Development
Reflecting on the American Society of Clinical Oncology annual meeting, I’m left thinking about…
cancer drug development
There are 6 articles under this tag
Private vs Public: Privacy in Trials
There was quite a ruckus in the cancer drug development community when Memorial Sloan Kettering Cancer…
Social Media & Cancer Drugs: Conversation, not Promotion
*This post was originally posted at Xconomy.* (Updated to include Lilly COI in table based…
Walls and Fences – Biotechnology Analogy
After the Biotechnology Industry Organization (BIO) international convention last week, I spent the weekend…
Pharma Strategy Blog, AACR and Ribonucleases
The American Association for Cancer Research annual meeting has come and gone for 2012…
Is Safety a Strategy in Cancer Drug Development?
The ASCO meeting led me to a number of general themes but my attempt…